JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KUHS, M. L.
Right arrow Articles by TATUM, A. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by KUHS, M. L.
Right arrow Articles by TATUM, A. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 61, Issue 4, 451-458, 1937
Copyright © 1937 by American Society for Pharmacology and Experimental Therapeutics


SPECIFICITY RELATIONSHIPS BETWEEN TYPES OF ARSENICALS AND TYPES OF TRYPANOSOMES

M. L. KUHS 1 and A. L. TATUM 1

1 From the Department of Pharmacology of the University of Wisconsin, Madison

Several organic arsenicals were found to be effective in curing Trypanosoma lewisi infection in the rat, but were ineffective on infections caused by Trypanosoma equiperdum. Members of another group of organic arsenicals were found to be effective in curing T. equiperdum infections in the rat but were inactive in T. lewisi infections. Those compounds effecting cures on the T. lewisi infections possessed aliphatic side-chains which were acidic in nature, while those compounds curing the T. equiperdum infections possessed side-chains of a basic nature. Specificity of drug type to types of trypanosomes appears to be clearly indicated.

The trivalent arsenicals were more effective curative agents than the pentavalent arsonic acid derivatives on the T. lewisi infections. A shift in the aliphatic side-chain from the ortho position to the para position with respect to the arsenic radical produced a marked increase in therapeutic efficiency. A curative arsenical was found to be more highly bound to parasites "in vitro" than was a non-curative arsenical. "In vitro" binding power, therefore, appears to bear a definite relationship to "in vivo" curing capacity.

Submitted on July 24, 1937







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1937 by the American Society for Pharmacology and Experimental Therapeutics.